Clear cell carcinoma, the most common type of RCC, is characterized by the activation of angiogenic signaling pathways such as vascular endothelial growth factor (VEGF), and hypoxia-inducible factor (HIF) through mutations in the Von Hippel-Lindau (VHL) gene 2-4. This evidence concerns the gene VEGFA and clear cell adenocarcinoma.